Foreign Establishments Lead China's Business-Launching-Purposed Investment Market

来源 :China's Foreign Trade | 被引量 : 0次 | 上传用户:ligc66
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Zero2ipo, the domestic famous company offering researchand consulting service relates to capital investment for es-tablishing business (for reading convenience hereinafter re-ferred to as CIEB), officially released the middle-term re-port on China’s CIEB for 2003 today.The report pointedout that the total amount of CIEB of the second quarter inChina reached US$133 million that sharply dropped 45% Zero2ipo, the domestic famous company offering researchand consulting service to capital investment for es-tablishing business (for reading convenience hereinafter re-ferred to as CIEB), officially released the middle-term re-port on China’s CIEB for 2003 today.The report pointedout that the total amount of CIEB of the second quarter inChina reached $ 133 million that sharply dropped 45%
其他文献
本文拟通过针对疫情防控所采取的措施及临床试验质量保证的角度,探讨重大突发公共卫生事件下药物临床试验的管理对策.面对重大突发公共卫生事件,临床试验机构应根据相关规定
免疫检查点抑制剂(ICPi)是一种靶向作用于表达在T细胞表面的免疫抑制分子的单克隆抗体,其作为一种新兴的免疫治疗药物,已广泛用于治疗各种实体肿瘤和血液系统肿瘤.然而,ICPi
新型冠状病毒肺炎疫情蔓延下,临床试验工作的节奏遭受巨大挑战,南京大学医学院附属鼓楼医院基于疫情期间临床试验工作指引和相关法规,通过设计调查问卷,调研临床试验工作开展
目的:本研究旨在调查我国儿童(儿童妇女)专科临床试验机构试验药物管理现状,为设完善儿科临床试验药物管理体系提供依据.方法:使用问卷调查法,对中国儿科人群药物临床试验协
吸入剂相较于普通制剂在剂型、装置及作用方式等方面有其特殊性,吸入剂生物等效性评价若按照普通制剂的评价方法进行,可能导致所得结果的准确度降低,故吸入剂的生物等效性评